Key Findings

The study identifies a mutation in the Serratia marcescens AmpC beta-lactamase gene (Thr64→Ile) that leads to high-level resistance to ceftazidime and cefpirome. This mutation enhances the catalytic efficiency of the enzyme towards these antibiotics.